Bio Asia-Taiwan Exhibition has been opened recently，National Biotechnology Research Park—BioHub has officially launched the” Biomedical Innovation Acceleration Base”，the former vice president Mr. Chen Chien-jen was invited to launch the opening ceremony. Mr. Chen Chien-jen encouraged further investment in the field of bio-tech research, achieve promotion of excellent bio-tech research and development, at the beginning of 2004, the Taipei City Government first launched the “Taipei Bio-tech Awards” specified for bio-tech industry. The award is designed for the innovation of the field, exploration and development, technology transfer, product marketing, breeding, etc., the important points of the field, and the three major domain experts in bio-tech, finance, and financial-intelligence are invited to make up the investigation committee, to select the city's standard schools and institutes to present trophies and prizes.
Over the years, the “Taipei Bio-tech Awards”has gained prestige in the sectors of bio-tech industry, government and academia, based on a rigorous, impartial and professional review mechanism. A total of 79 million TWD had been awarded to 182 out of 994 contenders. Most of the award-winning companies are under rapid growth, and nearly 60% of them have successfully gone on market. Their products or technologies have won high regards on international bio-tech conferences and earned a total of 430 million TWD through technology licensing. The joint efforts of the bio-tech industry and the authority have made the “Taipei Bio-tech Awards” also known as the “Bio-tech Oscar” or the field – which has provided an excellent platform for the best bio-tech firms of Taiwan to promote corporate image and business reputation in international arena!
Same as the previous years, screening and recognition of the internationalization of the biotechnology industry, innovative value and technology undertaking elite models, the research industry enthusiastically participate to compete the “Innovation Award”, “Globalizing Award”, and “Technology Cooperation Award”, all of the outstanding biotechnology companies and academic research units have proposed creative masterpieces in purpose to win the 2020 Bio-tech Awards!
As one of the largest specialty contact lenses manufacturers in the Asia Pacific region, Brighten Optix has successfully integrated R&D, advanced manufacturing and clinical research. Brighten Optix also strives to provide a comprehensive range of eyecare services, has more than five decades of experience in Taiwan, dedicate to improve modern people's eyesight. This award – development of contact lens polymer material for Orthokeratology，the theory on how orthokeratology correct myopia is using the ocular characteristic of corneal reshaping, to build the most suitable design for Oriental cornea, wearing the innovative high oxygen permeability orthokeratology during sleep at night, reshape the cornea to temporarily correct nearsightedness and achieve the effect of myopia control during waking hours.
The Head of R&D, Brighten Optix, Richard Wu said, Brighten Optix team is composed by a group of dedicated professional in optometry, this team has abundant clinical experience and great R&D resources, which can focus on developing various customized contact lens design for Oriental cornea. By integrating R&D and 50 years of fitting experiences, with collaboration between R&D manufacturing team and management team, to meet customers’needs is the goal of Brighten Optix. This award is not only affirmed the results of Brighten Optix in the field of optometry, and also encourage everyone to focus more on the innovation of material, technology and clinical research, with a view to becoming the best Made In Taiwan manufacturer in the field of optometry.